Arcturus Therapeutics In... (ARCT)
NASDAQ: ARCT
· Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT
Arcturus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 117.5M | 135.17M | 138.39M | 142.47M | 147.03M | 110.62M | 157.75M | 292.72M | 262.71M | 280.24M | 205.75M | 51.5M | 40.57M | 15.48M | 12.36M | 8.8M | 8.7M | 9.02M |
Cost of Revenue | 1.72M | 2.62M | 3.52M | 3.52M | 3.42M | 55.19M | 105.5M | 126.96M | 163.85M | 149.37M | 143.05M | 151.5M | 159.21M | 166.7M | 171.86M | 163.51M | 135.81M | 98.08M |
Gross Profit | 52.92M | 98M | 100.31M | 106.71M | 98.23M | 10.05M | 6.87M | 117.25M | 98.86M | 130.87M | 62.7M | -100M | -118.64M | -151.23M | -159.5M | -154.71M | -127.11M | -89.06M |
Operating Income | -72.57M | -82.08M | -95.67M | -80.55M | -89.12M | -123.37M | -78.2M | 61.52M | 44.03M | 77.31M | 12.18M | -146.92M | -163.93M | -195.56M | -202.85M | -196.29M | -163.41M | -119.73M |
Interest Income | -2.83M | -1.25M | n/a | 22.69M | 19.05M | 18.16M | 17.36M | 12.29M | 8.73M | 5.65M | 2.58M | 950K | 698K | 720K | 754K | 739K | 671K | 555K |
Pretax Income | -60.38M | -68.57M | -80.94M | -62.38M | -70.59M | -105.2M | -27.89M | 102.2M | 82.26M | 112.67M | 10.64M | -146.66M | -165.48M | -198.5M | -203.68M | -196.12M | -163.03M | -118.72M |
Net Income | -60.16M | -68.2M | -80.94M | -62.64M | -71.96M | -107.3M | -29.73M | 99.33M | 81.05M | 112.04M | 9.32M | -146.69M | -166.27M | -199.29M | -203.68M | -196.12M | -163.03M | -118.72M |
Selling & General & Admin | 47.31M | 48.39M | 51.92M | 51.23M | 51.34M | 53.15M | 52.06M | 52.22M | 51.34M | 49.1M | 46.07M | 45.02M | 43.39M | 42.44M | 41.45M | 39.68M | 34.39M | 28.77M |
Research & Development | 147.39M | 154.15M | 172.83M | 155.87M | 167.81M | 184.13M | 182.33M | 182.49M | 169.1M | 154.63M | 147.75M | 153.4M | 161.11M | 168.6M | 173.76M | 165.41M | 137.71M | 99.98M |
Other Expenses | -40.9M | -40.9M | -62.53M | -60.77M | -47.33M | -47.33M | -26.25M | -26.49M | -800K | -800K | -244K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 153.79M | 161.64M | 162.22M | 146.33M | 171.82M | 189M | 207.18M | 207.27M | 218.69M | 202.93M | 193.58M | 198.42M | 204.5M | 211.04M | 215.21M | 205.09M | 172.1M | 128.75M |
Interest Expense | n/a | n/a | n/a | 4K | 24K | 24K | 767K | 1.55M | 2.3M | 3.03M | 3M | 2.92M | 2.87M | 2.85M | 2.67M | 2.16M | 1.64M | 1.12M |
Selling & Marketing Expenses | n/a | -900K | -900K | -1.72M | -1.72M | -815K | -815K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 180.89M | 189.63M | 206.44M | 195.39M | 194.58M | 210.86M | 212.82M | 208.07M | 218.69M | 202.93M | 193.58M | 198.42M | 204.5M | 211.04M | 215.21M | 205.09M | 172.1M | 128.75M |
Income Tax Expense | -17.06M | -17.22M | -3K | 263K | 1.37M | 2.1M | 1.83M | 2.87M | 1.21M | 633K | 1.32M | 84K | 829K | 734K | -56K | 54K | 74K | 264K |
Shares Outstanding (Basic) | 27.13M | 27.11M | 27M | 27.06M | 26.97M | 26.88M | 26.63M | 26.57M | 26.56M | 26.55M | 26.51M | 26.47M | 26.43M | 26.38M | 26.35M | 26.34M | 26.32M | 26.24M |
Shares Outstanding (Diluted) | 27.13M | 27.11M | 27M | 27.06M | 26.97M | 26.88M | 26.63M | 26.57M | 26.56M | 27.15M | 27.08M | 26.47M | 26.43M | 26.38M | 26.36M | 26.34M | 26.32M | 26.24M |
EPS (Basic) | -1.83 | -2.13 | -2.61 | -1.82 | -2.57 | -3.91 | -1 | 3.75 | 3.06 | 4.22 | 0.34 | -5.56 | -6.31 | -7.56 | -7.74 | -7.46 | -6.33 | -4.81 |
EPS (Diluted) | -1.83 | -2.13 | -2.61 | -1.82 | -2.57 | -3.91 | -1.04 | 3.61 | 2.92 | 4.08 | 0.24 | -5.56 | -6.31 | -7.56 | -7.74 | -7.46 | -6.33 | -4.81 |
EBITDA | -55.32M | -60.17M | -69.69M | -59.33M | -67.99M | -102.8M | -25.07M | 104.42M | 88.81M | 119.78M | 17.44M | -142.05M | -161.03M | -194.45M | -201.03M | -194.19M | -161.72M | -117.83M |
EBIT | -55.41M | -63.6M | -73.22M | -72.82M | -81.4M | -116.01M | -37.96M | 101.77M | 86.58M | 117.85M | 15.8M | -143.61M | -162.23M | -195.4M | -202M | -194.96M | -162.65M | -118.84M |
Depreciation & Amortization | 2.53M | 3.43M | 3.54M | 3.53M | 3.45M | 3.25M | 2.92M | 2.66M | 2.23M | 1.93M | 1.57M | 1.33M | 1.23M | 1.13M | 1.22M | 1.18M | 1.09M | 1.01M |